Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients
Authors
Keywords
Hepatocellular carcinoma (HCC), Serglycin (SRGN), Invasion, Prognosis, Biomarker
Journal
MEDICAL ONCOLOGY
Volume 30, Issue 4, Pages -
Publisher
Springer Nature
Online
2013-08-30
DOI
10.1007/s12032-013-0707-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Delayed Contraction of the CD8+ T Cell Response toward Lymphocytic Choriomeningitis Virus Infection in Mice Lacking Serglycin
- (2014) M. Grujic et al. JOURNAL OF IMMUNOLOGY
- Evaluation of Midkine as a Diagnostic Serum Biomarker in Hepatocellular Carcinoma
- (2013) W.-W. Zhu et al. CLINICAL CANCER RESEARCH
- Cell-surface serglycin promotes adhesion of myeloma cells to collagen type I and affects the expression of matrix metalloproteinases
- (2013) Antonis Skliris et al. FEBS Journal
- SIRT2 overexpression in hepatocellular carcinoma mediates epithelial to mesenchymal transition by protein kinase B/glycogen synthase kinase-3β/β-catenin signaling
- (2013) Juan Chen et al. HEPATOLOGY
- Expression of integrin-linked kinase in adenoid cystic carcinoma of salivary glands correlates with epithelial–mesenchymal transition markers and tumor progression
- (2013) Dan Zhao et al. MEDICAL ONCOLOGY
- Down-regulated KLF17 expression is associated with tumor invasion and poor prognosis in hepatocellular carcinoma
- (2013) Fu-Yao Liu et al. MEDICAL ONCOLOGY
- Sorafenib versus capecitabine in the management of advanced hepatocellular carcinoma
- (2013) Omar Abdel-Rahman et al. MEDICAL ONCOLOGY
- Serglycin in Health and Diseases
- (2012) Olivia J. Scully et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma
- (2012) Mary Maluccio et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Serglycin participates in retention of -defensin in granules during myelopoiesis
- (2011) A. Glenthoj et al. BLOOD
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Association of Specific Genotypes in Metastatic Suppressor HTPAP with Tumor Metastasis and Clinical Prognosis in Hepatocellular Carcinoma
- (2011) N. Ren et al. CANCER RESEARCH
- Serglycin Is a Theranostic Target in Nasopharyngeal Carcinoma that Promotes Metastasis
- (2011) X.-J. Li et al. CANCER RESEARCH
- Prevention of recurrence after resection of hepatocellular carcinoma: A daunting challenge
- (2011) Ronnie T.P. Poon HEPATOLOGY
- Overexpression of High-Mobility Group Box 2 Is Associated with Tumor Aggressiveness and Prognosis of Hepatocellular Carcinoma
- (2010) J.-H. Kwon et al. CLINICAL CANCER RESEARCH
- Serglycin Is a Major Proteoglycan in Polarized Human Endothelial Cells and Is Implicated in the Secretion of the Chemokine GROα/CXCL1
- (2010) Astri J. Meen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Serglycin proteoglycan: Regulating the storage and activities of hematopoietic proteases
- (2009) Gunnar Pejler et al. BIOFACTORS
- Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters
- (2009) Ke Hao et al. BMC CANCER
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. JNCI-Journal of the National Cancer Institute
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serglycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice
- (2007) D. S. Woulfe et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now